The case counts seem to be dropping. But health officials say that's because violence in the Democratic Republic of Congo makes it difficult to get good data. And now U.S. assistance is being disrupte...

The first batch of generic version of dolutegravir (DTG), an antiretroviral drug used to treat HIV,  arrived in Colombia on Thursday as part of a compulsory license, marking a significant milestone fo...

"This is a global disaster. USAID supports HIV testing, treatment and prevention in over 50 countries. This freeze on funding has has shut down clinics and…

A group of civil society organisations has written the following joint letter calling for the South African government to provide a coordinated emergency response to address the healthcare emergency c...

Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to widespread confusion. The backtracking didn’t help.

The good news first: HIV science has made remarkable progress. While we still lack a vaccine or cure, a single dose of a new long-acting injectable drug can

According to WHO, 400,000 people developed DR-TB in 2023, yet only 44% (175, 923) of them were treated for it. …

Danish drug giant found to have failed to accurately report spending even after admitting to errors